Research brief · 2026-09-09
How a Receptor Works: The Lock-and-Key Idea
Almost every peptide story eventually comes back to a receptor, so it is worth knowing what one is. A receptor is a protein, most often embedded in the outer membrane of a cell. One end faces outward into the blood or the fluid around the cell. The other end faces inward. Its whole job is to recognise one particular molecule on the outside and pass a message to the inside.
The classic way to picture this dates to 1894, when the chemist Emil Fischer proposed that enzymes and the molecules they act on fit together like a lock and a key. The idea carried over to receptors. The signalling molecule, whether a hormone, a peptide or a drug, is the key. The receptor is the lock. Only a key of the right shape fits, and when it does, the receptor changes shape and sets off a chain of events inside the cell. That specificity is why a hormone can travel past millions of cells and only act on the ones carrying its receptor.
In 1958, Daniel Koshland refined the model. Real locks are rigid, but proteins are not. Koshland's induced-fit model, published in the Proceedings of the National Academy of Sciences, describes the receptor flexing and closing around its partner, more like a hand around a ball than a lock around a key. Standard textbooks such as Molecular Biology of the Cell now teach both pictures together.
This is not just chemistry trivia. A 2017 review by Hauser and colleagues in Nature Reviews Drug Discovery found that roughly a third of all approved drugs act on one receptor family alone, the G protein-coupled receptors. The GLP-1 receptor, the target of several prescription diabetes and weight medications, belongs to that family.
The limit of the lock-and-key picture is that it makes the story sound simpler than it is. The same key can produce different effects in different tissues, receptors can become less responsive with constant stimulation, and a molecule can fit a lock partially or block it entirely. Knowing a compound binds a receptor tells you nothing, on its own, about whether it helps or harms. That question needs trials, and any health decision belongs with a physician.
Sources
- Fischer E. Einfluss der Configuration auf die Wirkung der Enzyme (origin of the lock-and-key model)
- Berichte der deutschen chemischen Gesellschaft 1894
- Koshland DE Jr. Application of a theory of enzyme specificity to protein synthesis (induced-fit model)
- Proceedings of the National Academy of Sciences 1958
- Hauser AS, Attwood MM, Rask-Andersen M, Schiöth HB, Gloriam DE. Trends in GPCR drug discovery: new agents, targets and indications
- Nature Reviews Drug Discovery 2017
- Alberts B, et al. Molecular Biology of the Cell, 6th edition (cell signaling chapter)
- Garland Science 2015
Peptide Proof reports what studies found. We do not give medical advice, dosing guidance, or treatment recommendations.